Quaker Houghton · NYSE:KWR
Quaker Houghton — Quaker Chemical — Q3 2025 Earnings Presentation
15 slides from Quaker Houghton's earnings presentation, Oct 30, 2025
Slide 1: Quaker Houghton Third Quarter 2025 Results Investor Conference Call
Quaker Houghton Third Quarter 2025 Results Investor Conference Call
Slide 2: Regulation G and Forward-Looking Statements
Regulation G The attached charts include Company information that does not conform to generally accepted accounting principles (“GAAP”). Management believes that an analysis of this data is meaningful to investors because it provides insight with respect to ongoing operating results of the Company a
Slide 3: Non-GAAP Financial Information
The information included in this presentation includes non-GAAP (unaudited) financial information that includes EBITDA, adjusted EBITDA, adjusted EBITDA margin, non-GAAP operating income, non-GAAP operating margin, non-GAAP gross profit, non-GAAP gross margin, taxes on income before equity in net in
Slide 4: Speakers
Joe Berquist Chief Executive Officer, President Tom Coler Executive Vice President, Chief Financial Officer Robert T. Traub Senior Vice President, General Counsel & Corporate Secretary Jeffrey Schnell Vice President, Investor Relations ©2025 Quaker Houghton. All Rights Reserved 4 Speakers
Slide 5: Highlights
Highlights © 2025 Quaker Houghton. All Rights Reserved $494m Net Sales $83m Adjusted EBITDA1 5 $2.08 Non-GAAP Earnings per Diluted Share1 $51m Operating Cash Flow 1 This is a non-GAAP measure, refer to the reconciliations of our non-GAAP measures to their most comparable GAAP measures provided withi
Slide 6: Financial Snapshot
©2025 Quaker Houghton. All Rights Reserved 6 Financial Snapshot (Unaudited; Dollars in millions, unless otherwise noted) (1) Certain amounts may not calculate due to rounding (2) These are non-GAAP measures. Refer to the reconciliations of our non-GAAP measures to their most comparable GAAP measures
Slide 7: Sales volumes increased 3% Y/Y in Q3'25 driven by new business wins
Sales volumes increased 3% Y/Y in Q3’25 driven by new business wins across all regions Sales volumes increased 1% in Q3’25 compared to Q2’25 Total Company Volume Trend1 (kilograms) 7 ©2025 Quaker Houghton. All Rights Reserved Q1 2022 Q2 2022 Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2
Slide 8: Adjusted EBITDA
©2025 Quaker Houghton. All Rights Reserved 8 Adjusted EBITDA1 (dollars in millions) Generated $83m of adjusted EBITDA in Q3’25 and adjusted EBITDA margins of 16.8% 1 This is a non-GAAP measure, refer to the reconciliations of our non-GAAP measures to their most comparable GAAP measures provided with
Slide 9: Leverage and Liquidity Update
• Total debt of $875 million • Cash and cash equivalents of $172 million • Net debt of $703 million • Leverage of 2.4x as of September 30, 20251 ◦ In April 2025, we funded the Dipsol acquisition with borrowings under our existing credit facility • Operating well within bank covenants ◦ Bank leverage
Slide 10: Appendix Actual and Non-GAAP Results
Appendix Actual and Non-GAAP Results
Slide 11: Non-GAAP Gross Profit and Operating Income Reconciliation
©2025 Quaker Houghton. All Rights Reserved 11 Non-GAAP Gross Profit and Operating Income Reconciliation (Unaudited; Dollars in thousands, unless otherwise noted) Three Months Ended September 30, Nine Months Ended September 30, Non-GAAP Operating Income and Margin Reconciliations 2025 2024 2025 2024
Slide 12: Adjusted EBITDA Reconciliation
©2025 Quaker Houghton. All Rights Reserved 12 Adjusted EBITDA Reconciliation (Unaudited; Dollars in thousands, unless otherwise noted) EBITDA, Adjusted EBITDA, Adjusted EBITDA Margin Reconciliations: Three Months Ended September 30, Nine Months Ended September 30, 2025 2024 2025 2024 Net income (los
Slide 13: Adjusted EBITDA Reconciliation
©2025 Quaker Houghton. All Rights Reserved 13 Adjusted EBITDA Reconciliation (Unaudited; Dollars in thousands, unless otherwise noted) EBITDA, Adjusted EBITDA, and Adjusted EBITDA Margin Reconciliations: Twelve Months Ended December 31, 2024 2023 2022 2021 Net income (loss) attributable to Quaker Ch
Slide 14: Non-GAAP EPS Reconciliation
©2025 Quaker Houghton. All Rights Reserved 14 Non-GAAP EPS Reconciliation Three Months Ended September 30, Nine Months Ended September 30, Non-GAAP Earnings per Diluted Share Reconciliations 2025 2024 2025 2024 GAAP earnings (loss) per diluted share attributable to Quaker Chemical Corporation common
Slide 15: Segment Performance
©2025 Quaker Houghton. All Rights Reserved 15 Segment Performance (Unaudited; Dollars in thousands, except per share amounts) Three Months Ended September 30, Nine Months Ended September 30, 2025 2024 2025 2024 Net sales Americas $ 222,787 $ 220,275 $ 657,560 $ 673,546 EMEA 143,900 134,135 413,101 4